Clinical trial
Efficacy and Safety of AAE581 in Postmenopausal Women With…
NCT00170911 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00170911 |
|---|---|
| Title | Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis. |
| Official title | Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis. |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | AAE581 |
| Enrollment | 160 |
| Start date | Mar 1, 2005 |
| Primary completion | Dec 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 2, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: